Diversify Advisory Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$564K Sell
14,390
-1,158
-7% -$53.4K 0.01% 877
2026
Q2
$772K Buy
+15,548
New +$668K 0.01% 727
2026
Q1
– Sell
-8,187
Closed -$510K – 638
2025
Q4
$510K Sell
8,187
-735
-8% -$37.6K 0.02% 601
2025
Q3
$438K Sell
8,922
-95
-1% -$5.56K 0.01% 605
2025
Q2
$449K Buy
9,017
+766
+9% +$52.1K 0.02% 571
2025
Q1
$538K Sell
8,251
-2,598
-24% -$215K 0.03% 348
2024
Q4
$936K Sell
10,849
-3,074
-22% -$332K 0.05% 237
2024
Q3
$1.62M Sell
13,923
-2,711
-16% -$362K 0.09% 188
2024
Q2
$2.34M Sell
16,634
-16,040
-49% -$2.13M 0.13% 143
2024
Q1
$4.17M Buy
+32,674
New +$3.89M 0.25% 86

Other funds holding NVO

Diversify Advisory Services's NVO Position: Q3 2026 in Review

Diversify Advisory Services reduced its Novo Nordisk (NVO) stake by 7.4% in Q3 2026, selling an estimated $53.4K and leaving 14,390 shares worth $564K. The position accounts for 0.01% of the portfolio, ranked #877.

Diversify Advisory Services first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.17M in Q1 2024. 281 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Diversify Advisory Services held 14,390 shares of Novo Nordisk worth $564K as of Q3 2026.
  • Diversify Advisory Services sold 1,158 Novo Nordisk shares in Q3 2026, an estimated $53.4K.
  • Novo Nordisk made up 0.01% of Diversify Advisory Services's portfolio in Q3 2026, its #877 holding.
  • Diversify Advisory Services first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
  • Diversify Advisory Services's Novo Nordisk position peaked at $4.17M in Q1 2024.
  • 281 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Diversify Advisory Services's 13F filing for Q3 2026, filed 20 Oct 2026.